These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 8212820)
1. Vaccination-induced HI antibody to influenza A(H1N1) viruses in poorly primed adults under circumstances of low antigenic drift. Pyhälä R; Kinnunen L; Kumpulainen V; Ikonen N; Kleemola M; Cantell K Vaccine; 1993; 11(10):1013-7. PubMed ID: 8212820 [TBL] [Abstract][Full Text] [Related]
2. Vaccination-induced HI antibody response to intraepidemic influenza A(H3N2) virus variants of the 1996-1997 epidemic season. Pyhälä R; Ikonen N; Santanen R; Haanpää M; Visakorpi R; Jäppinen P; Valle M J Med Virol; 2001 Nov; 65(3):584-9. PubMed ID: 11596097 [TBL] [Abstract][Full Text] [Related]
3. Possible correlation between low antigenic drift of A(H1N1) influenza viruses and induction of HI antibodies. Iorio AM; Zei T; Neri M; Alatri A Eur J Epidemiol; 1996 Dec; 12(6):589-94. PubMed ID: 8982618 [TBL] [Abstract][Full Text] [Related]
4. Immune response to inactivated influenza virus vaccine: antibody reactivity with epidemic influenza B viruses of two highly distinct evolutionary lineages. Pyhälä R; Kleemola M; Kumpulainen V; Vartiainen E; Lappi S; Pönkä A; Cantell K Vaccine; 1992; 10(9):631-6. PubMed ID: 1502842 [TBL] [Abstract][Full Text] [Related]
5. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949 [TBL] [Abstract][Full Text] [Related]
6. Altered antibody response to influenza H1N1 vaccine in healthy elderly people as determined by HI, ELISA, and neutralization assay. Remarque EJ; de Bruijn IA; Boersma WJ; Masurel N; Ligthart GJ J Med Virol; 1998 May; 55(1):82-7. PubMed ID: 9580890 [TBL] [Abstract][Full Text] [Related]
7. Influenza vaccination of dialysis patients: cross-reactivity of induced haemagglutination-inhibiting antibodies to H3N2 subtype antigenic variants is comparable with the response of naturally infected young healthy adults. Antonen JA; Pyhälä R; Hannula PM; Ala-Houhala IO; Santanen R; Ikonen N; Saha HH Nephrol Dial Transplant; 2003 Apr; 18(4):777-81. PubMed ID: 12637648 [TBL] [Abstract][Full Text] [Related]
8. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948 [TBL] [Abstract][Full Text] [Related]
9. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity. Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA J Hyg (Lond); 1983 Jun; 90(3):351-9. PubMed ID: 6863909 [TBL] [Abstract][Full Text] [Related]
10. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1). Schmidt S; Süss J; Oehring H; Schmidt J Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540 [TBL] [Abstract][Full Text] [Related]
11. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection. Masurel N; Laufer J J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638 [TBL] [Abstract][Full Text] [Related]
12. Serological evaluation of an influenza A virus cold-adapted reassortant live vaccine, CR-37 (H1N1), in Japanese adult volunteers. Yamane N; Nakamura Y; Yuki M; Odagiri T; Ishida N J Hyg (Lond); 1984 Apr; 92(2):231-42. PubMed ID: 6707472 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model. Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959 [TBL] [Abstract][Full Text] [Related]
14. Cross-reaction but no avidity change of the serum antibody response after influenza vaccination. Brokstad KA; Cox RJ; Major D; Wood JM; Haaheim LR Vaccine; 1995 Nov; 13(16):1522-8. PubMed ID: 8578836 [TBL] [Abstract][Full Text] [Related]
15. Antigenic analysis of recent H1N1 influenza viruses with monoclonal antibodies. Yamada A; Cao MS; Imanishi J; Oyama S; Abe A; Katagiri S Acta Virol; 1991 Aug; 35(4):343-9. PubMed ID: 1724874 [TBL] [Abstract][Full Text] [Related]
16. Antigenic and molecular heterogeneity in recent swine influenza A(H1N1) virus isolates with possible implications for vaccination policy. de Jong JC; Heinen PP; Loeffen WL; van Nieuwstadt AP; Claas EC; Bestebroer TM; Bijlsma K; Verweij C; Osterhaus AD; Rimmelzwaan GF; Fouchier RA; Kimman TG Vaccine; 2001 Aug; 19(31):4452-64. PubMed ID: 11483271 [TBL] [Abstract][Full Text] [Related]
17. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies. Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855 [TBL] [Abstract][Full Text] [Related]
18. Recycling of H1N1 influenza A virus in man--a haemagglutinin antibody study. Masurel N; Heijtink RA J Hyg (Lond); 1983 Jun; 90(3):397-402. PubMed ID: 6863911 [TBL] [Abstract][Full Text] [Related]
19. A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses. van de Witte S; Nauta J; Montomoli E; Weckx J Vaccine; 2018 Sep; 36(40):6030-6038. PubMed ID: 29709447 [TBL] [Abstract][Full Text] [Related]
20. HI antibody kinetics in adult volunteers immunized repeatedly with inactivated trivalent influenza vaccine in 1990-1992. Pyhälä R; Kumpulainen V; Alanko S; Forsten T Vaccine; 1994 Aug; 12(10):947-52. PubMed ID: 7975836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]